<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref034">
 <label>[34]</label>
 <mixed-citation publication-type="journal">
  <string-name>
   <surname>West</surname>
   <given-names>T</given-names>
  </string-name>, 
  <string-name>
   <surname>Hu</surname>
   <given-names>Y</given-names>
  </string-name>, 
  <string-name>
   <surname>Verghese</surname>
   <given-names>PB</given-names>
  </string-name>, 
  <string-name>
   <surname>Bateman</surname>
   <given-names>RJ</given-names>
  </string-name>, 
  <string-name>
   <surname>Braunstein</surname>
   <given-names>JB</given-names>
  </string-name>, 
  <string-name>
   <surname>Fogelman</surname>
   <given-names>I</given-names>
  </string-name>, 
  <string-name>
   <surname>Budur</surname>
   <given-names>K</given-names>
  </string-name>, 
  <string-name>
   <surname>Florian</surname>
   <given-names>H</given-names>
  </string-name>, 
  <string-name>
   <surname>Mendonca</surname>
   <given-names>N</given-names>
  </string-name>, 
  <string-name>
   <surname>Holtzman</surname>
   <given-names>DM</given-names>
  </string-name> (
  <year>2017</year>) 
  <article-title>Preclinical and clinical development of ABBV-8E12, a humanized anti-tau antibody, for treatment of Alzheimer’s disease and other tauopathies</article-title>. 
  <source>J Prev Alzheimers Dis</source>
  <volume>4</volume>, 
  <fpage>236</fpage>–
  <lpage>241</lpage>.
  <pub-id pub-id-type="pmid">29181488</pub-id>
 </mixed-citation>
</ref>
